Reykjavik, Iceland

Zoltan Fulop

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zoltan Fulop: Innovator in Ophthalmic Pharmaceutical Delivery

Introduction

Zoltan Fulop is a notable inventor based in Reykjavik, Iceland. He has made significant contributions to the field of ophthalmic pharmaceutical delivery. With a focus on innovative compositions, Fulop has been awarded 2 patents for his groundbreaking work.

Latest Patents

Fulop's latest patents include the preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery. This invention relates to ophthalmic compositions that contain solid complexes of active pharmaceutical ingredients and cyclodextrin. The method of preparation and the uses of these compositions are also detailed in the patent. The compositions can include an active agent drug/cyclodextrin complex that is substantially dissolved in an aqueous eye drop vehicle. The ophthalmic composition is generally in the form of a microsuspension, which includes an active agent complex having a diameter of less than about 100 micrometers.

Career Highlights

Zoltan Fulop has established himself as a key figure in the pharmaceutical industry. His work focuses on enhancing the delivery of active pharmaceutical ingredients through innovative formulations. He is currently associated with Oculis SA, where he continues to develop advanced ophthalmic solutions.

Collaborations

Fulop collaborates with Thorsteinn Loftsson, a fellow innovator in the field. Their partnership has led to advancements in the development of ophthalmic compositions.

Conclusion

Zoltan Fulop's contributions to ophthalmic pharmaceutical delivery highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing the field through research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…